• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非编码 RNA 在调控癌症中的失巢凋亡和锚定非依赖性生长中的作用。

The Role of Noncoding RNAs in the Regulation of Anoikis and Anchorage-Independent Growth in Cancer.

机构信息

Department of Biomedical Science and Research Institute for Bioscience & Biotechnology, Hallym University, Chunchon 24252, Korea.

出版信息

Int J Mol Sci. 2021 Jan 10;22(2):627. doi: 10.3390/ijms22020627.

DOI:10.3390/ijms22020627
PMID:33435156
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7827914/
Abstract

Cancer is a global health concern, and the prognosis of patients with cancer is associated with metastasis. Multistep processes are involved in cancer metastasis. Accumulating evidence has shown that cancer cells acquire the capacity of anoikis resistance and anchorage-independent cell growth, which are critical prerequisite features of metastatic cancer cells. Multiple cellular factors and events, such as apoptosis, survival factors, cell cycle, EMT, stemness, autophagy, and integrins influence the anoikis resistance and anchorage-independent cell growth in cancer. Noncoding RNAs (ncRNAs), such as microRNAs (miRNAs) and long noncoding RNAs (lncRNAs), are dysregulated in cancer. They regulate cellular signaling pathways and events, eventually contributing to cancer aggressiveness. This review presents the role of miRNAs and lncRNAs in modulating anoikis resistance and anchorage-independent cell growth. We also discuss the feasibility of ncRNA-based therapy and the natural features of ncRNAs that need to be contemplated for more beneficial therapeutic strategies against cancer.

摘要

癌症是一个全球性的健康问题,癌症患者的预后与转移有关。癌症转移涉及多步过程。越来越多的证据表明,癌细胞获得了抗失巢凋亡和锚定非依赖性细胞生长的能力,这是转移性癌细胞的关键先决特征。多种细胞因子和事件,如细胞凋亡、存活因子、细胞周期、上皮间质转化、干细胞特性、自噬和整合素,影响着癌症的抗失巢凋亡和锚定非依赖性细胞生长。非编码 RNA(ncRNA),如 microRNAs(miRNAs)和长非编码 RNA(lncRNAs),在癌症中失调。它们调节细胞信号通路和事件,最终导致癌症的侵袭性。本文综述了 miRNA 和 lncRNA 在调节抗失巢凋亡和锚定非依赖性细胞生长中的作用。我们还讨论了 ncRNA 治疗的可行性,以及 ncRNA 的天然特性,这些特性需要考虑在内,以制定更有效的抗癌治疗策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a565/7827914/a4384173546b/ijms-22-00627-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a565/7827914/cf9b78543575/ijms-22-00627-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a565/7827914/4090cf610e62/ijms-22-00627-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a565/7827914/a4384173546b/ijms-22-00627-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a565/7827914/cf9b78543575/ijms-22-00627-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a565/7827914/4090cf610e62/ijms-22-00627-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a565/7827914/a4384173546b/ijms-22-00627-g003.jpg

相似文献

1
The Role of Noncoding RNAs in the Regulation of Anoikis and Anchorage-Independent Growth in Cancer.非编码 RNA 在调控癌症中的失巢凋亡和锚定非依赖性生长中的作用。
Int J Mol Sci. 2021 Jan 10;22(2):627. doi: 10.3390/ijms22020627.
2
The potential roles and mechanisms of non-coding RNAs in cancer anoikis resistance.非编码 RNA 在癌症失巢凋亡抵抗中的潜在作用和机制。
Mol Cell Biochem. 2022 May;477(5):1371-1380. doi: 10.1007/s11010-022-04384-6. Epub 2022 Feb 10.
3
Noncoding RNAs in DNA Damage Response: Opportunities for Cancer Therapeutics.DNA损伤反应中的非编码RNA:癌症治疗的机遇
Methods Mol Biol. 2018;1699:3-21. doi: 10.1007/978-1-4939-7435-1_1.
4
Noncoding RNAs in cancer and cancer stem cells.癌症与癌症干细胞中的非编码RNA
Chin J Cancer. 2013 Nov;32(11):582-93. doi: 10.5732/cjc.013.10170.
5
Emerging Role of Non-Coding RNAs in Esophageal Squamous Cell Carcinoma.非编码 RNA 在食管鳞状细胞癌中的新兴作用。
Int J Mol Sci. 2019 Dec 30;21(1):258. doi: 10.3390/ijms21010258.
6
Non-coding RNAs targeting notch signaling pathway in cancer: From proliferation to cancer therapy resistance.非编码 RNA 靶向癌症中的 Notch 信号通路:从增殖到癌症治疗耐药性。
Int J Biol Macromol. 2022 Dec 1;222(Pt A):1151-1167. doi: 10.1016/j.ijbiomac.2022.09.203. Epub 2022 Oct 1.
7
Noncoding RNAs in osteosarcoma: Implications for drug resistance.非编码 RNA 在骨肉瘤中的作用:与耐药性的关系。
Cancer Lett. 2021 Apr 28;504:91-103. doi: 10.1016/j.canlet.2021.02.007. Epub 2021 Feb 12.
8
A comprehensive review of web-based non-coding RNA resources for cancer research.基于网络的非编码 RNA 资源在癌症研究中的全面综述。
Cancer Lett. 2017 Oct 28;407:1-8. doi: 10.1016/j.canlet.2017.08.015. Epub 2017 Aug 18.
9
Reiterating the Emergence of Noncoding RNAs as Regulators of the Critical Hallmarks of Gall Bladder Cancer.再次强调非编码 RNA 作为胆囊癌关键特征调控因子的出现。
Biomolecules. 2021 Dec 8;11(12):1847. doi: 10.3390/biom11121847.
10
Noncoding RNAs regulate alternative splicing in Cancer.非编码 RNA 调控癌症中的可变剪接。
J Exp Clin Cancer Res. 2021 Jan 6;40(1):11. doi: 10.1186/s13046-020-01798-2.

引用本文的文献

1
Hedgehog pathway, cell cycle, and primary cilium.刺猬信号通路、细胞周期与初级纤毛。
Cell Death Discov. 2025 Jul 3;11(1):302. doi: 10.1038/s41420-025-02605-7.
2
Single-Cell RNA Sequencing Reveals Extensive Heterogeneity and Unique Gene Trajectories in Non-Transformed and Transformed Human Lung Epithelial Cells: Insights into the Role of LncRNAs in Tumor Heterogeneity.单细胞RNA测序揭示非转化和转化人肺上皮细胞中的广泛异质性和独特基因轨迹:lncRNAs在肿瘤异质性中作用的见解
Int J Mol Sci. 2025 Feb 16;26(4):1690. doi: 10.3390/ijms26041690.
3
Mycobacteria Treatment Inhibits Bladder Cancer Cell Migration, Invasion, and Anchorage-Independent Growth.

本文引用的文献

1
Metastatic Colonization: Escaping Immune Surveillance.转移定植:逃避免疫监视
Cancers (Basel). 2020 Nov 16;12(11):3385. doi: 10.3390/cancers12113385.
2
The inhibitory effect of microRNA-1827 on anoikis resistance in lung adenocarcinoma A549 cells via targeting caveolin-1.miR-1827 通过靶向细胞窖蛋白-1抑制肺腺癌细胞 A549 的失巢凋亡抵抗。
Acta Biochim Biophys Sin (Shanghai). 2020 Oct 19;52(10):1148-1155. doi: 10.1093/abbs/gmaa102.
3
Participation of MicroRNAs in the Treatment of Cancer with Phytochemicals.植物化学物质治疗癌症中 MicroRNAs 的作用。
分枝杆菌治疗可抑制膀胱癌细胞的迁移、侵袭和非锚定依赖性生长。
Int J Mol Sci. 2024 Dec 3;25(23):12997. doi: 10.3390/ijms252312997.
4
Bone sialoprotein facilitates anoikis resistance in lung cancer by inhibiting miR-150-5p expression.骨涎蛋白通过抑制 miR-150-5p 的表达促进肺癌的抗失巢凋亡。
J Cell Mol Med. 2024 Oct;28(20):e70155. doi: 10.1111/jcmm.70155.
5
Targeting Ovarian Cancer Stem Cells by Dual Inhibition of the Long Noncoding RNA HOTAIR and Lysine Methyltransferase EZH2.靶向长链非编码 RNA HOTAIR 和赖氨酸甲基转移酶 EZH2 的双重抑制治疗卵巢癌干细胞。
Mol Cancer Ther. 2024 Nov 4;23(11):1666-1679. doi: 10.1158/1535-7163.MCT-23-0314.
6
The role of miRNAs as biomarkers in breast cancer.微小RNA(miRNAs)作为乳腺癌生物标志物的作用。
Front Oncol. 2024 May 15;14:1374821. doi: 10.3389/fonc.2024.1374821. eCollection 2024.
7
Anoikis-related genes as potential prognostic biomarkers in gastric cancer: A multilevel integrative analysis and predictive therapeutic value.失巢凋亡相关基因作为胃癌潜在的预后生物标志物:多层次综合分析及预测治疗价值。
IET Syst Biol. 2024 Apr;18(2):41-54. doi: 10.1049/syb2.12088. Epub 2024 Feb 20.
8
A novel anoikis-related gene signature identifies LYPD1 as a novel therapy target for bladder cancer.一种新型的与细胞凋亡相关的基因特征,鉴定 LYPD1 为膀胱癌的一个新的治疗靶点。
Sci Rep. 2024 Feb 8;14(1):3198. doi: 10.1038/s41598-024-53272-0.
9
Identification and validation of anoikis-related lncRNAs for prognostic significance and immune microenvironment characterization in ovarian cancer.卵巢癌中与失巢凋亡相关lncRNAs的鉴定、验证及其预后意义和免疫微环境特征分析
Aging (Albany NY). 2024 Jan 15;16(2):1463-1483. doi: 10.18632/aging.205439.
10
Qizhu Anti-Cancer Recipe promotes anoikis of hepatocellular carcinoma cells by activating the c-Jun N-terminal kinase pathway.芪术抗癌方通过激活c-Jun氨基末端激酶途径促进肝癌细胞失巢凋亡。
Heliyon. 2023 Nov 13;9(11):e22089. doi: 10.1016/j.heliyon.2023.e22089. eCollection 2023 Nov.
Molecules. 2020 Oct 14;25(20):4701. doi: 10.3390/molecules25204701.
4
MiR-137 promotes anoikis through modulating the AKT signaling pathways in Pancreatic Cancer.微小RNA-137通过调节胰腺癌中的AKT信号通路促进失巢凋亡。
J Cancer. 2020 Aug 28;11(21):6277-6285. doi: 10.7150/jca.44037. eCollection 2020.
5
Targeting AGTR1/NF-κB/CXCR4 axis by miR-155 attenuates oncogenesis in glioblastoma.靶向 AGTR1/NF-κB/CXCR4 轴的 miR-155 抑制胶质母细胞瘤的发生。
Neoplasia. 2020 Oct;22(10):497-510. doi: 10.1016/j.neo.2020.08.002. Epub 2020 Sep 5.
6
Cytosolic ME1 integrated with mitochondrial IDH2 supports tumor growth and metastasis.细胞质 ME1 与线粒体 IDH2 整合支持肿瘤生长和转移。
Redox Biol. 2020 Sep;36:101685. doi: 10.1016/j.redox.2020.101685. Epub 2020 Aug 13.
7
Extracellular Vesicles (EVs) and Pancreatic Cancer: From the Role of EVs to the Interference with EV-Mediated Reciprocal Communication.细胞外囊泡(EVs)与胰腺癌:从EVs的作用到对EV介导的相互通讯的干扰
Biomedicines. 2020 Aug 3;8(8):267. doi: 10.3390/biomedicines8080267.
8
miR-7 Reduces Breast Cancer Stem Cell Metastasis via Inhibiting RELA to Decrease ESAM Expression.微小RNA-7通过抑制RELA降低内皮细胞选择素样分子表达从而减少乳腺癌干细胞转移。
Mol Ther Oncolytics. 2020 Jun 4;18:70-82. doi: 10.1016/j.omto.2020.06.002. eCollection 2020 Sep 25.
9
METTL3 Promotes Tumorigenesis and Metastasis through BMI1 mA Methylation in Oral Squamous Cell Carcinoma.METTL3 通过 BMI1 的 mA 甲基化促进口腔鳞状细胞癌的发生和转移。
Mol Ther. 2020 Oct 7;28(10):2177-2190. doi: 10.1016/j.ymthe.2020.06.024. Epub 2020 Jun 24.
10
MicroRNA-527 Induces Proliferation and Cell Cycle in Esophageal Squamous Cell Carcinoma Cells by Repressing PH Domain Leucine-Rich-Repeats Protein Phosphatase 2.微小RNA-527通过抑制PH结构域富含亮氨酸重复序列蛋白磷酸酶2诱导食管鳞状细胞癌细胞增殖和细胞周期。
Dose Response. 2020 May 22;18(2):1559325820928687. doi: 10.1177/1559325820928687. eCollection 2020 Apr-Jun.